Gary Taylor

Stock Analyst at TD Cowen

(2.55)
# 2,360
Out of 5,058 analysts
148
Total ratings
50.51%
Success rate
0.05%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $14.34
Upside: +74.34%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $21.04
Upside: +99.62%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $6.12
Upside: +104.25%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.51
Upside: +289.56%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $228.90
Upside: +17.08%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $16.33
Upside: -20.39%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $481.06
Upside: -8.54%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $309.09
Upside: +97.03%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $35.95
Upside: +147.57%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $138.12
Upside: +173.68%
Maintains: Hold
Price Target: $183$220
Current: $227.94
Upside: -3.48%
Maintains: Hold
Price Target: $139$150
Current: $115.20
Upside: +30.21%
Maintains: Outperform
Price Target: $30$26
Current: $22.55
Upside: +15.31%
Upgrades: Outperform
Price Target: $39$35
Current: $15.71
Upside: +122.79%
Maintains: Outperform
Price Target: $564$585
Current: $316.37
Upside: +84.91%
Maintains: Market Perform
Price Target: $3$6
Current: $14.08
Upside: -57.39%
Maintains: Outperform
Price Target: $10$8
Current: $6.18
Upside: +29.45%
Upgrades: Outperform
Price Target: $242$329
Current: $271.99
Upside: +20.96%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.32
Upside: +29.31%
Initiates: Market Perform
Price Target: $17
Current: $5.01
Upside: +239.32%
Downgrades: Underweight
Price Target: $28$20
Current: $194.25
Upside: -89.70%
Maintains: Neutral
Price Target: $33$20
Current: $22.93
Upside: -12.78%
Downgrades: Underweight
Price Target: n/a
Current: $2.90
Upside: -